Most Read Articles
Roshini Claire Anthony, 2 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 5 days ago
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
Jairia Dela Cruz, 6 days ago
Male smokers under the age of 50 years are at risk of developing ischaemic stroke, and this risk increases with the number of cigarettes smoked daily, according to data from the Stroke Prevention in Young Men Study.
Yesterday
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.

Remission crucial for work productivity in RA patients

11 Aug 2017

Achieving remission is important to ensure work performance and activity in patients with rheumatoid arthritis (RA), according to a recent study.

A total of 1,274 consecutive patients were included in this study that sought to identify factors relevant to work and activity impairment in patients with RA. Researchers used the Work Productivity and Activity Impairment questionnaire to measure work and activity impairment, and examined related clinical factors.

Of the RA patients, 67.4 percent reported work and activity impairment. Pain and nonremission were associated with activity impairment and presenteeism, based on multivariable linear regression analyses. Patients in remission reported significantly less activity impairment and presenteeism as compared to those with low disease activity.

“Remission achievement is essential for ensuring work performance and activity,” researchers said.

These findings support an earlier study, which found that productivity loss was common in patients in the first years of RA who are in paid work and was associated with work characteristics and adverse clinical outcomes. [Rheumatology (Oxford) 2012;51:375-84]

In a related review, Suzanne Verstappen from the Arthritis Research UK Centre for Epidemiology said that many RA patients have to take sick leave or even stop working because of their condition despite changes in RA management in the last 15 years. Additionally, those remaining in paid work may face problems due to RA resulting in productivity loss while at work. [Best Pract Res Clin Rheumatol 2015;29:495-511]

“The costs attributed to absenteeism and presenteeism have been estimated to be very high, and they even exceed direct costs,” Verstappen said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 2 days ago

The combined use of piperacillin and tazobactam does not appear to be a suitable alternative to meropenem for patients with bloodstream infections caused by ceftriaxone-resistant Escherichia coli (E. coli) or Klebsiella pneumoniae (K. pneumoniae), according to results of the MERINO* trial.

Tristan Manalac, 5 days ago
Taking oral antibiotics appears to increase the risk of nephrolithiasis, according to a recent study. Moreover, the risk seems to be compounded for individuals with recent antibiotic exposure and those who were exposed at a younger age.
Jairia Dela Cruz, 6 days ago
Male smokers under the age of 50 years are at risk of developing ischaemic stroke, and this risk increases with the number of cigarettes smoked daily, according to data from the Stroke Prevention in Young Men Study.
Yesterday
Early renin-angiotensin-aldosterone system (RAAS) blockade with renin-angiotensin system inhibitors (RASI) leads to better short- and long-term renal outcomes in systemic lupus erythematosus (SLE) patients with antiphospholipid-associated nephropathy (aPLN), according to a study, adding that this renal protective effect is independent of RASI’s antihypertensive and antiproteinuric effects.